MobiHeathNews (HIMSS): In-Depth: Defining the Burgeoning Field of Digital Therapeutics
As digital and connected technologies continue to stake their claim in the industry, the last few years have seen the rise of a new type of health technology product — one that promises measurable health outcomes validated by traditional clinical trials.
"Jo Masterson, cofounder and chief operating officer of 2Morrow, said that her company has a handful of clinical trials completed and another on the way for its behavioral therapy app. While her company does consider its products to be digital therapeutics and is ultimately interested in FDA, she said that 2Morrow is willing to give the process some time."
